Fundz

Biofrontera reported raising $3.68 Million in an initial SEC Form D filing, from an offering of $3.68 Million

PUBLIC · BFRINov 04, 2022

Amount Raised

$3.68 Million

$3.68 Million sold, per SEC Form D (first sale Oct 25, 2022)

Round Type

Seed

WoburnBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Quick answer

Biofrontera raised $3.68 Million in a Seed round, dated October 25, 2022. Biofrontera is based in Woburn, Massachusetts, United States.

How much did Biofrontera raise?
Biofrontera raised $3.68 Million in a Seed round on October 25, 2022.
What does Biofrontera do?
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT.
Where is Biofrontera based and how big is it?
Biofrontera is based in Woburn, Massachusetts, United States. Fundz records about 70 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Biofrontera that raised within 45 days of this round, from Fundz verified event records.

  • Parabilis Medicines raised $178M (Series D) on November 21, 2022.
  • Parabilis Medicines raised $178M on November 17, 2022.
  • Os Therapies raised $2M on November 16, 2022.
  • MBX Biosciences, Inc. raised $47M on November 7, 2022.
  • ExPLoRNA Therapeutics raised an undisclosed amount (Funding Round) on December 7, 2022.
  • Solid Biosciences raised $9.2M on December 2, 2022.

Who to call at Biofrontera, and when

A new round usually means Biofrontera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biofrontera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biofrontera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biofrontera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biofrontera

Location

Woburn, Massachusetts, United States

About

Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz® with the RhodoLED® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biofrontera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Biofrontera's next move

See what Strategic adds

Biofrontera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.